IV thrombolysis and statins.

Objective: To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in stroke patients receiving IV thrombolysis (IVT).Methods: In a pooled observational study of 11 IVT databases, we compared outcomes between statin users and nonusers. Outcome measures were excellent 3-month outcome (modified Rankin scale 0-1) and ICH in 3 categories. We distinguished all ICHs (ICH(all)), symptomatic ICH based on the criteria of the ECASS-II trial (SICH(ECASS-II)), and symptomatic ICH based on the criteria of the National Institute of Neurological Disorders and Stroke (NINDS) trial (SICH(NINDS)). Unadjusted and adjusted odds ratios (OR) with 95% confidence intervals were calculated.Results: Among 4,012 IVT-treated patients, 918 (22.9%) were statin users. They were older, more often male, and more frequently had hypertension, hypercholesterolemia, diabetes, coronary heart disease, and concomitant antithrombotic use compared with nonusers. Fewer statin users (35.5%) than nonusers (39.7%) reached an excellent 3-month outcome (OR(unadjusted) 0.84 [0.72-0.98], p = 0.02). After adjustment for age, gender, blood pressure, time to thrombolysis, and stroke severity, the association was no longer significant (0.89 [0.74-1.06], p = 0.20). ICH occurred by trend more often in statin users (ICH(all) 20.1% vs 17.4%; SICH(NINDS) 9.2% vs 7.5%; SICH(ECASS-II) 6.9% vs 5.1%). This difference was statistically significant only for SICH(ECASS-II) (OR = 1.38 [1.02-1.87]). After adjustment for age, gender, blood pressure, use of antithrombotics, and stroke severity, the OR(adjusted) for each category of ICH (ICH(all) 1.15 [0.93-1.41]; SICH(ECASS-II) 1.32 [0.94-1.85]; SICH(NINDS) 1.16 [0.87-1.56]) showed no difference between statin users and nonusers.Conclusion: In stroke patients receiving IVT, prior statin use was neither an independent predictor of functional outcome nor ICH. It may be considered as an indicator of baseline characteristics that are associated with a less favorable course. Neurology (R) 2011;77:888-895

Iowa Department of Transportation Major Items - Preliminary Quantity Report, February 17, 2015; With Addendums

Weekly letting report.

La motivació com estratègia psicològica en la interacció d'entrenadors i esportistes en iniciació esportiva

Un dels aspectes més importants en iniciació esportiva és la motivació. Si aconseguim que els nostres jugadors estiguin motivats per realitzar la pràctica esportiva obtindrem per part seva una major implicació per les tasques d’entrenament i evitarem l’abandonament prematur de la pràctica esportiva per falta de motivació. Els jugadors en les seves primeres etapes s’inicien en l’esport per motius intrínsecs i hem d’esbrinar que és el que vol el nostre grup al principi de temporada. El qüestionari de motius de pràctica esportiva ens servirà per saber que és el que volen els nostres jugadors i com hem de plantejar les tasques d’entrenament per adequar-les a les seves motivacions. La interacció entrenador – jugadors és l’altre punt a tractar en aquest treball ja que la motivació extrínseca produïda per l’entrenador durant els partits i els entrenaments tindrà una repercussió en la motivació intrínseca del nen. El CBAS és un mètode adequat per identificar les conductes de l’entrenador quan interactua amb els seus jugadors durant els partits i quins aspectes s’han de millorar. L’objectiu d’aquest treball és plantejar estratègies per conèixer i millorar la motivació dels jugadors incidint sobre la motivació intrínseca i extrínseca d’aquests mitjançant la interacció que tenen l’entrenador i els jugadors.

Avaliação agronômica de um biossólido industrial para a cultura do milho

O objetivo deste trabalho foi avaliar a viabilidade agronômica de um biossólido industrial para a cultura do milho. O experimento foi realizado no campo, em um Cambissolo distrófico, nos anos agrícolas 1999/2000 e 2000/2001. A aplicação de 0, 6, 12, 18 e 24 Mg ha-1 de biossólido base seca, suplementado com K2O nos dois anos e 30% do P2O5 recomendado no segundo ano, foi comparada à adubação mineral completa. O biossólido melhorou a fertilidade do solo, o estado nutricional e a produtividade do milho, que apresentou resposta quadrática às doses aplicadas, atingindo a máxima de 9.992 kg ha-1 de grãos com 22,5 Mg ha-1 de biossólido, superando em 21% a adubação mineral e em 74% o controle. Mesmo na maior dose aplicada, os teores de nutrientes, Na e metais pesados no biossólido não causaram fitotoxicidade. A equivalência em produtividade à adubação mineral (7.895 kg ha-1) foi obtida com 10 Mg ha-1 de biossólido. Com base na equivalência ao NPK, o valor do biossólido foi estimado em R$ 43,70 Mg-1 base seca e R$ 8,74 Mg-1 base úmida. Considerando-se o custo de transporte, a aplicação deste biossólido é economicamente viável numa distância de até 66 km da fonte geradora.

La pertinence de la Global Health pour la Suisse

L'une des premières activités du groupe spécialisé "Global Health", créé au sein de la société de discipline médicale Santé Publique Suisse, a été de formuler une définition appropriée au contexte helvétique du terme de "Global Health" (santé globale). La "Global Health est un espace destiné à la recherche, à la pratique et aux règles y afférents, qui met la priorité sur l'amélioration de la santé, en général, et sur un accès équitable à la santé pour tous, en particulier. La Global Health répond aux questions de santé transnationales et s'intéresse aux déterminants et aux possibilités de solution. Elle implique beaucoup de disciplines, tant du secteur médical que d'autres domaines, promouvant ainsi la collaboration interdisciplinaire; elle encourage la bonne gouvernance pour anticiper et s'adapter à un environnement qui change rapidement ". A l'avenir, une plateforme sera créée dans le but d'offrir un accès aux expériences internationales et de les fructifier en Suisse mais aussi de partager les expériences acquises ici localement, avec des partenaires internationaux tels que les associations européenne et mondiale de santé publique. Last but not least, le groupe spécialisé susmentionné va plaider pour une compréhension large et commune de la Global Health.

Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectives.

For decades intravitreal chemotherapy (IViC) remained virtually banished from the therapeutic armamentarium against retinoblastoma, except as a heroic attempt of salvage before enucleation in only eyes with refractory vitreous seeding. Very recently, we have initiated a reappraisal of this route of administration by (1) profiling eligibility criteria, (2) describing a safety-enhanced injection procedure, (3) adjusting the tumoricidal dose of melphalan, and (4) reporting an unprecedented efficacy in terms of tumor control of vitreous seeding. Since then, intravitreal chemotherapy is being progressively implemented worldwide with great success, but still awaits formal validation by the ongoing prospective phase II clinical trial. As far as preliminary results are concerned, IViC appears to achieve complete vitreous response in 100% of the 35 newly recruited patients irrespective of the previous treatment regimen, including external beam radiotherapy and/or intra-arterial melphalan. In other words, vitreous seeding, still considered as the major cause of primary and secondary enucleation, can now be controlled by IViC. However, sterilization of vitreous seeding does not necessarily translate into eye survival, unless the retinal source of the seeds receives concomitant therapy. In conclusion, IViC, an unsophisticated and cost-effective treatment, is about to revolutionize the eye survival prognosis of vitreous disease in advanced retinoblastoma.

Wood waste processing in Iowa, 1996

The objective of this report is to gain a better understanding of the wood waste market in Iowa through surveying the processors of wood waste. A survey was sent out by the Iowa Department of Natural Resources Management Assistance Division to 147 public waste management organizations and private businesses with a questionnaire which asked for details of any wood waste processing operation.

Frequency and chronology of extraintestinal manifestations in the Swiss Inflammatory Bowel Disease Cohort

Background: Data on the frequency of extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) is scarce, especially the one evaluating the time of occurrence of the EIM relative to IBD diagnosis. Aim: To assess the type and frequency of EIM in IBD patients and to evaluate when EIMs occur relative to IBD diagnosis. Methods: Analysis of data from the Swiss Inflammatory Bowel Disease Cohort (SIBDCS) which collects data on a large sample of IBD patients from hospitals and private practices across Switzerland starting in 2005. While parametric data are shown as mean ± SD, non-parametric data are presented as median and interquartile range (IQR). Results: A total of 1143 patients were analyzed (572 (50%) female, mean age 42.1 ± 14.4 years): 629 (55%) with Crohn's disease (CD), 501 (44%) with ulcerative colitis (UC), and 13 (1%) with indeterminate colitis (IC). Of 1143 patients, 374 (32.7%) presented with EIM (65% with CD, 33% with UC, 2% with IC). Of those patients suffering from EIMs, 37.4% presented with one, 41.7% with two, 12.4% with three, 5.3% with four, and 3.2% with five EIM during their lifetime. The IBD patients initially presented with the following EIMs: peripheral arthritis (PA) 63.4%, ankylosing spondylitis (AS) 8.1%, primary sclerosing cholangitis (PSC) 6.0%, uveitis 5.7%, oral aphthosis 5.7%, erythema nodosum (EN) 5.0%, pyoderma gangrenosum 1.8%, psoriasis 0.7%. While 92.9% of EIM occurred once IBD diagnosis was established (median 72 months, IQR 9-147 months, p < 0.001), 7.1% of EIMs preceded IBD diagnosis (median time 28 months before IBD diagnosis, IQR 7-60 months). Over a course of a lifetime, IBD patients presented with the following EIM (total exceeds 100 due to potential presence of multiple EIM): peripheral arthritis 69.3%, oral aphthosis 23%, ankylosing spondylitis 19.4%, uveitis 15.5%, erythema nodosum 14.5%, PSC 7.8%, pyoderma gangrenosum 6%, psoriasis 2.8%. Conclusion: EIMs frequently occur in a lifetime of IBD patients. The vast majority of patients present with EIMs once IBD diagnosis has been established. IBD patients most often present with peripheral arthritis, ankylosing spondylitis and PSC as their first EIM. However, peripheral arthritis, oral aphthosis, and ankylosing spondylitis are the most common EIMs in a lifetime of IBD patients.

Horae ad usum romanum.

F. 1-12v. Calendrier d’Autun en français, inscrit à l’or et à l’encre, alternativement rouge et bleue : 1er juin, « s. Reverien » [év. d’Autun] ; 12 juin, en or : « s. Nazaire » [révélation] ; 28 juil., « ss. Nazaire et Celse » ; 4 août, « s. Cassien [év. d’Autun] » ; 1er sept., « s. Ladre » [Lazare] ; 5 sept., «ste Royne » [Reine d’Alise] ; 19 sept., « s. Soigne » [Seine] ; 24 sept., « Andoche » [év. d’Autun] ; 2 oct., « Legier » [év. d’Autun] ; 20 oct., « revelacion s. Ladre » ; 17 déc., « s. Lazaire » ; 20 déc., « s. Nasaire » [21 déc., dédicace de Saint-Nazaire d’Autun]. F. 13-18. Péricopes évangéliques : Io 1, 1-14, suivi du suffrage adressé à l’apôtre ; Mt 2, 1-12 ; Lc 1, 26-38 ; Mc 16, 14-20. Les évangiles de Mathieu et de Luc sont incomplets du début par suite de la perte du premier fol. F. 19-78v. Heures de la Vierge à l’usage de Rome. Les heures de tierce, sexte, none et vêpres sont incomplètes du début par suite de la perte du premier feuillet. F. 79-82v. “Obsecro te…”, prière au masculin (éd. Leroquais, Livres d’heures, II, 347). F. 83-86v. Office de la Croix « De sancta cruce ». F. 87-90v. Office du Saint Esprit « De sancto Spiritu ». F. 91-107v. Psaumes de la pénitence , suivis des Litanies, incomplet du premier feuillet. A noter, parmi les confesseurs, « sancte Ludovice », Louis d’Anjou, év. de Toulouse. F. 107v-154. Office des morts à l’usage de Rome. « In agenda mortuorum ad vesperas ». F. 154v-159. Addition du XVe siècle : « Oraison de saint Sebastien », suffrage ; [Oraison pour les trépassés] « Avete omnes fideles anime quorum corpora… coronemur... Domine Jhesu Christe salus et liberatio animarum... jubeas. Per... » (154v et 159). — Additions du début du XVIe siècle. « Veni creator Spiritus... spiritus. Amen » ; « De s. Johanne Baptista » ; « Salve regina misericordie vita... ostende » ; « Domine non sum digna… animeam meam », à noter la forme féminine (156-158). — Sur le verso du f. 158, a été cousu un petit feuillet de parchemin portant l’oraison « O passio magna, o profunda vulnera, o effusio sanguinis, o dulcis dulcedo, o mortis amaritudo, da michi vitam eternam. Amen. Pater. Ave Maria. Credo ».